Greater Cambridge Area
Accomplished leader with extensive pharmaceutical industry experience in drug and diagnostic development, having led or supported precision medicine approaches for over 25 Phase I-III clinical trials. PhD in cancer biology (translational science) with proven expertise in biomarker discovery, validation, patient-centric approaches, and health authority regulatory interactions. Effective communication and interpersonal skills demonstrated by deep stakeholder management experience, excellent presentation skills and a robust publication record. Compassionate, inclusive leader experienced in line and matrix management. Motivates teams to push scientific boundaries, streamline processes, and maximize efficiency while maintaining compliance. Detail-oriented professional with ability to maintain a clear strategic view.
Team lead within the diagnostic and laboratory science function driving line and matrix teams across multiple therapy areas to deliver key milestones, optimize resources and elevate stakeholder communications. Guided strategy and execution that enabled multiple Phase 3 investment decisions, diagnostic test/partner selection, laboratory set-up, study oversight, and regulatory submissions across multiple therapeutic areas.
Senior member of the Molecular Diagnostics team delivering critical technical expertise across project and portfolio levels; led diagnostic development for complex Phase 3 studies, provided matrix leadership across a diagnostics portfolio, and advanced to line-manage and develop junior scientists
Delivered scientific and technical expertise to drug project teams, supporting the development and implementation of validated diagnostics for prospective patient selection. The role was primarily a diagnostic technical lead but I was also interim laboratory manager for 1 year covering maternity leave (2015-2016).
Conducted research as part of Molecular Therapeutics for Cancer Ireland (MTCI), a Strategic Research Cluster dedicated to advancing personalised cancer treatment through the development of anti-cancer drugs and the identification of companion biomarkers to predict patient response to specific therapies or combination regimens
Awarded SFI Short Term Travel Fellowship to conduct additional research towards PhD. Through collaboration with the host lab, I further explored microRNAs regulating cancer cell aggression & treatment as well as existence of exosomes in circulation